More than 250,000 people did not renew their private health insurance during the 12 months to March this year, according to the latest annual Roy Morgan survey involving 50,000 face-to-face interviews with consumers, including 20,000 private-health-insurance-fund members.
The 256,000 finding was up on last year’s 182,000, making it the highest level of cancellations in five years.
Being “too expensive” is the main reason that consumers give for dropping out of health insurance, which has risen to 53.3% over the year, up from 47.1% in the previous year.
The second major concern among those who didn’t renew is to do with the gap in coverage by their fund. In the current year there was a big increase in the proportion saying that their major reason for leaving was “too much out-of-pocket expense” with 19.1%, up from 12.8% last year.
Nearly one in six (15.5%) of members who didn’t renew said “Medicare suits my needs”, up from only 5.3% last year. It appears that there are an increasing number of people seeing no real value in having private health insurance, given its cost and perceived benefits over simply relying on Medicare.
Over the year there was also an increase in concerns regarding service, with 11.6% saying that they didn’t renew because of “poor service’”, up from 2.3%
Read More >
Swiss pharmaceutical giant Novartis on 16 May announced the retirement of its group general legal counsel, Mr Felix Ehrat, as he apologised for payments made by the company to United States President Donald Trump’s personal lawyer Mr Michael Cohen.
The announcement came after Novartis was dragged into the scandal over Mr Cohen’s payment of $US130,000 to US adult film actor Ms ‘Stormy’ Daniels just days before the 2016 presidential election.
On 9 May, Novartis said it had signed a one-year contract for $US100,000 a month with Mr Cohen’s firm in February 2017, seeking advice on the new Trump administration’s public health policy.
Following a meeting with Mr Cohen, the company changed its mind, although Novartis was contractually obliged to pay him the full $1.2 million.
US special counsel Robert Mueller is investigating the payments as a strand of his wider investigation into Russian interference in the 2016 presidential election and allegations of collusion and obstruction of justice by the Trump campaign.
Mr Trump originally denied having an affair with Ms Daniels, who goes by her stage name rather than her real name of Stephanie Clifford, more than a decade ago. But one of the newest members of Mr Trump’s legal team, former federal prosecutor and New York mayor Rudy Giuliani, has
Read More >
Eyecare Plus has taken top spot in Canstar Blue’s 2018 customer satisfaction ratings for optometrists, recording five stars in most research categories, including service and advice, range of products and after-sale service.
The report on the survey said 14% of adults admitted that they get their eyes tested less frequently than every two years with another check-up; the majority of respondents said they get their eyes checked every one to two years (60%), while 22% do so every six to 12 months and 3% visit their optometrist every six months, or more frequently.
Sixty-three per cent of Australians said they always visit the same optometrist, with good customer service and support the most common reason for doing so, well ahead of convenience and price.
The report said:
- Eyecare Plus was the only chain to score five stars for overall satisfaction, while also earning top marks in most other research areas.
- Budget Eyewear, OPSM, Optical Superstore and Specsavers all achieved four stars overall, with Optical Superstore standing out with five stars for service and advice and value for money.
- Big W Optical and Laubman & Pank both received just three stars overall, with a mix of four and three stars across the board.
Additional information: www.canstarblue.com.au/health-beauty/optometrist/.
Optometry Australia says it has increased its media coverage over the past three years by 33 per cent with much of the coverage focused on raising awareness of eye health.
Editorial coverage since 2014-15 has risen to 363 pieces to date this financial year and the organisation is confident of achieving additional quality articles by 30 June, the association says.
The increase aligns with goals within the organisation’s strategic plan to promote optometry, optometrists and community eye health, the association says.
It also supports Good vision for life’s consumer campaign goals which aim to highlight the need to have regular eye examinations throughout life and to motivate consumers to book an eye examination.
British retail giant Marks and Spencer is to trial optician practices in five of its stores, Optician magazine reports.
The in-store concessions will be run by Galaxy Optical and branded as M&S Opticians.
The five locations are: Bolton, York, Derby, Manchester and London’s Westfield White City.
A spokesperson for Marks and Spencer said: “As part of our transformation plan we’re adapting our UK store estate to better appeal to our existing customers and attract new ones.
“One way we’re repositioning space is welcoming concessions into M&S stores. We’re already running a trial with Wasabi in our Foodhalls and now we’re extending this program with M&S Opticians.
“Working with an expert partner, Galaxy Optician Services, we’ll be carefully monitoring the trial.”
Concessions are scheduled for opening in the northern summer.
The Roy Morgan survey’s finding, reported on 17 May, that 53 per cent of the 256,000 people did not renew their private health insurance cover on costs grounds in the year to March comes as no surprise.
The people who did so attributed their decision to seeing no real value in having private health insurance, given its cost and perceived benefits over simply relying on Medicare.
Even with all of the private-health-insurance cover in the world, the gaps continue to increase alarmingly between fees charged and the miserable benefits paid, whether it’s for in-practice procedures or for in-hospital, so much so that any concept of an affordable universal health scheme has largely become a dream.
The rot set in when several major private health funds were demutualised by the suits and listed on the sharemarket, such as Medibank Private and NIB, and/or bought by bigger companies, such as British fund Bupa.
That means a profit margin has to be included in their operations and results so as to keep shareholders happy, otherwise they would turn on the suits (a.k.a. directors and senior staff} and boot them out.
It’s little if anything to do with health, rather the interests of the suits and those they command.
Regrettably, more and more like America every day.
How’s this for
Read More >